Analysts Set Cardinal Health, Inc. (NYSE:CAH) Price Target at $140.14

Cardinal Health, Inc. (NYSE:CAH) has been assigned a consensus recommendation of “Moderate Buy” from the fourteen research firms that are covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $140.86.

A number of equities analysts recently commented on the stock. Bank of America lifted their target price on shares of Cardinal Health from $150.00 to $155.00 and gave the stock a “buy” rating in a research report on Friday. Citigroup boosted their target price on Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research note on Friday, January 10th. Evercore ISI raised Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target on the stock in a research note on Tuesday, January 7th. JPMorgan Chase & Co. increased their price objective on Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. Finally, Wells Fargo & Company upped their price target on shares of Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th.

Cardinal Health Stock Up 2.1 %

Shares of CAH stock opened at $131.65 on Monday. The business has a 50-day moving average price of $129.33 and a two-hundred day moving average price of $122.48. Cardinal Health has a 12-month low of $93.17 and a 12-month high of $139.50. The firm has a market cap of $31.80 billion, a P/E ratio of 24.56, a price-to-earnings-growth ratio of 1.49 and a beta of 0.61.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, research analysts expect that Cardinal Health will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 annualized dividend and a yield of 1.54%. Cardinal Health’s payout ratio is 37.69%.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in CAH. Rothschild Investment LLC raised its holdings in Cardinal Health by 10.1% in the fourth quarter. Rothschild Investment LLC now owns 858 shares of the company’s stock worth $101,000 after purchasing an additional 79 shares in the last quarter. CSS LLC IL increased its stake in shares of Cardinal Health by 0.8% in the 4th quarter. CSS LLC IL now owns 11,190 shares of the company’s stock worth $1,323,000 after acquiring an additional 90 shares in the last quarter. Private Trust Co. NA lifted its position in Cardinal Health by 11.0% during the 4th quarter. Private Trust Co. NA now owns 930 shares of the company’s stock valued at $110,000 after acquiring an additional 92 shares during the period. Checchi Capital Advisers LLC lifted its position in Cardinal Health by 2.7% during the 4th quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company’s stock valued at $411,000 after acquiring an additional 93 shares during the period. Finally, TIAA Trust National Association boosted its stake in Cardinal Health by 4.5% during the fourth quarter. TIAA Trust National Association now owns 2,183 shares of the company’s stock worth $258,000 after acquiring an additional 94 shares in the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.